| Multi-resonant absorption in ultra-thin silicon solar cells with metallic nanowires I Massiot, C Colin, C Sauvan, P Lalanne, PR i Cabarrocas, JL Pelouard, ... Optics Express 21 (103), A372-A381, 2013 | 55 | 2013 |
| Cellular response to cetuximab in PTEN-silenced head and neck squamous cell carcinoma cell line J Mriouah, C Boura, S Pinel, AS Chretien, A Fifre, JL Merlin, B Faivre International journal of oncology 37 (6), 1555-1563, 2010 | 28 | 2010 |
| Tumor vascular responses to antivascular and antiangiogenic strategies: looking for suitable models J Mriouah, C Boura, M Thomassin, T Bastogne, D Dumas, B Faivre, ... Trends in biotechnology, 2012 | 20 | 2012 |
| Preclinical studies of pegylated-and non-pegylated liposomal forms of doxorubicin as radiosensitizer on orthotopic high-grade glioma xenografts P Chastagner, H Sudour, J Mriouah, M Barberi-Heyob, ... Pharmaceutical research 32, 158-166, 2015 | 18 | 2015 |
| PTEN expression is involved in the invasive properties of HNSCC: a key protein to consider in locoregional recurrence J Mriouah, C Boura, M Gargouri, F Plenat, B Faivre International journal of oncology 44 (3), 709-716, 2014 | 15 | 2014 |
| Signaling phosphoproteins in head and neck squamous cell carcinoma: relation with cellular sensitivity to cetuximab and interest of multiplex determination using Bio-Plex … JL Merlin, J Mriouah, G Dolivet, C Ramacci, M Rouyer, P Genin, ... Proc Amer Assoc Cancer Res 48, 2007 | 5 | 2007 |
| Fusogenic targeted liposomes as next-generation nanomedicine for prostate cancer JM Mriouah, RL Nesbitt, D Sosnowski, D Pink, R Duncan, A Ziljstra, ... Cancer Research 76 (14_Supplement), 2192-2192, 2016 | 1 | 2016 |
| Fusogenic liposomes: A novel therapeutic strategy to efficiently target and destroy prostate cancer J Mriouah, RL Nesbitt, D Pink, R Duncan, A Zijlstra, JD Lewis Cancer Research 74 (19_Supplement), 821-821, 2014 | 1 | 2014 |
| Fusogenic targeted liposomes: novel nanotherapy for specific treatment of prostate cancer J Mriouah, RL Nesbitt, S Richter, M Wuest, D Pink, D Sosnowski, ... Cancer Research 77 (13_Supplement), 5143-5143, 2017 | | 2017 |
| Radiolabeled fusogenic lipid nanoparticles for molecular imaging of prostate cancer using positron emission tomography (PET) S Richter, J Mriouah, A Medina, M Wuest, F Wuest, J Lewis JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 60, S440-S440, 2017 | | 2017 |
| Synergistic Antitumor Effect between Gefitinib and Fractionated Irradiation in S Pinel, J Mriouah, M Vandamme, A Chateau, F Plénat | | 2013 |
| Effect of cetuximab treatment on induction of angiogenesis by HNSCC cell line depending on PTEN expression J Mriouah, V Jouan-Hureaux, C Boura, JL Merlin, B Faivre Advances in the cellular and molecular biology of angiogenesis, 2011 | | 2011 |
| Etude de l'impact de la perte d'expression de PTEN sur la réponse au cetuximab et l'induction de l'angiogenèse par un modèle cellulaire de carcinome épidermoïde de la tête et … J Mriouah Nancy 1, 2010 | | 2010 |
| Resistance to cetuximab–implication of PTEN expression in the cellular sensitivity to cetuximab (Erbitux®) of Head and Neck Squamous Cell Carcinoma (HNSCC) J Mriouah, C Chartier, C Boura, A Fifre, I Fries, C Ramacci, JL Merlin, ... Ejc Supplements 6 (9), 112, 2008 | | 2008 |
| Cell Press Supplement—Trends 2013 J Mriouah, C Boura, M Thomassin, T Bastogne, D Dumas, B Faivre, ... | | |
Dominique DumasUniversité de LorraineVerified email at univ-lorraine.fr
